Search results
Covid-flu combination vaccine shows positive results in late-stage trial, Moderna says
KIMT Mason City· 59 minutes agoOn Monday, vaccine maker Moderna announced positive late-stage trial results for its Covid-flu...
Combined flu and Covid vaccine from Moderna shows positive trial results
PA Media: Science via Yahoo News· 18 minutes agoA combined flu and Covid vaccine from Moderna provokes a higher immune response than separate single...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 58 minutes agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
Moderna’s combo COVID and flu vaccine works better than stand-alone shots on the market, study finds
Market Watch· 57 minutes agoexperimental combination COVID and flu vaccine triggered better immune responses than stand-alone...
Moderna's two-in-one flu and Covid vaccine passes advanced trial
BBC News· 51 minutes agoDrug company Moderna says its combined flu and Covid vaccine, which targets the two diseases in a...
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
Investor's Business Daily· 58 minutes agoModerna said Monday its combination Covid and flu vaccine topped rivals from GSK and Sanofi, and its...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC New York· 59 minutes agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Moderna COVID/flu combo vaccine superior to separate shots in trial
Reuters via Yahoo News· 52 minutes agoIn the study, the combination using messenger RNA technology generated greater antibodies than...
Moderna's combo COVID and flu shot offers strong immunity in older adults during late stage trial
ABC News· 59 minutes agoModerna's combo flu and COVID vaccine provided a strong immune response in older adults, with levels...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
The Sacramento Bee· 59 minutes agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID vaccines in adults 50 years and older ...